I see the stock price hitting minimum 1.50 - 1.75 prior to announcement, if data is positive, this could double or triple in anticipation of the trial being "pivotal". Currently at 50M market cap, the share price is a bargain. Market Cap should be at least 200M.
Of course u can't be serious. NBY isn't even worth its current 50 M market cap. First of all, there is a very small chance the data will be positive and second NBY is years away from any kind of measurable revenues. Its a huge spec biotech and with the sector so over priced and bloated any kind of adjustment and this stock goes back to 50 cents and to its more appropriate, although still too high, market cap. Might I suggest u go to the gym and pump iron instead of NBY.